Search Within

MESOTHELIOMA

How Inhaled Asbestos Causes Scarring and Cancer

Journal: Current Respiratory Medicine Reviews
Volume: 14, Issue: 4
Page: 204-217
Authors: Arnold R. Brody*

JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 8
Page: 816-828
Authors: Ilaria Zanellato*, Donato Colangelo and Domenico Osella

Systemic Treatment of Chest Tumors: Highlighting Some Differences Between Eastern and Western Countries

Journal: Current Cancer Therapy Reviews
Volume: 14, Issue: 2
Page: 120-136
Authors: Victor HF Lee* and Dora L.W. Kwong

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 2
Page: 177-187
Authors: Pavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell and Evanthia Galanis*

Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target

Journal: Current Cancer Therapy Reviews
Volume: 13, Issue: 2
Page: 76-88
Authors: Bently P. Doonan, Kei Ohnuma, Long H. Dang, Chikao Morimoto and Nam H. Dang*

Immune Checkpoints Aberrations and Malignant Mesothelioma: Assessment of Prognostic Value and Evaluation of Therapeutic Potentials

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 9
Page: 1228-1233
Authors: Hadeer Mohamed, Mostafa Eltobgy and Omar Abdel-Rahman*

Surgical Options for Management of Malignant Pleural Mesothelioma in the Current Era

Journal: Current Respiratory Medicine Reviews
Volume: 12, Issue: 4
Page: 286-293
Authors: Mahmoud Loubani, Syed S. Qadri, Azar Hussain, Mubarak A. Chaudhry and Jack A. Kastelik

Epidemiology and Pathology of Malignant Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 12, Issue: 4
Page: 271-276
Authors: Jack A. Kastelik, Mahmoud Loubani, Michael Greenstone, Simon Hart and Anne Campbell

First Molecular Cytogenetic Characterization of Murine Malignant Mesothelioma Cell Line AE17 and In Silico Translation to the Human Genome

Journal: Current Bioinformatics
Volume: 12, Issue: 1
Page: 11-18
Authors: Eva Kubicova, Vladimir Trifonov, Fran Borovecki, Thomas Liehr, Martina Rincic, Nadezda Kosyakova and Shaymaa S. Hussein

The Role of Systemic Treatment and Radiotherapy in Malignant Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 12, Issue: 3
Page: 232-240
Authors: Michael Lind, Rachael Barton, Andrzej Wieczorek, Mahmoud Loubani and Jack A. Kastelik

Investigations of Malignant Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 12, Issue: 3
Page: 208-214
Authors: Jack A. Kastelik, Mahmoud Loubani, Gerard Avery, Anthony G. Arnold and Jaymin Morjaria

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

Journal: Clinical Cancer Drugs
Volume: 3, Issue: 2
Page: 76-86
Authors: Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier and Harald Dinter

Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma

Journal: MicroRNA
Volume: 5, Issue: 1
Page: 12-18
Authors: Anna Truini*, Simona Coco, Carlo Genova, Marco Mora, Maria G. Dal Bello, Irene Vanni, Angela Alama, Erika Rijavec, Giulia Barletta, Federica Biello, Claudia Maggioni and Francesco Grossi

Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies

Journal: Current Drug Targets
Volume: 17, Issue: 7
Page: 824-849
Authors: Stefano Thellung, Roberto E. Favoni, Roberto Würth, Mario Nizzari, Alessandra Pattarozzi, Antonio Daga, Tullio Florio and Federica Barbieri

Malignant Mesothelioma: Cell Survival Pathways and Radiation Therapy

Journal: Current Respiratory Medicine Reviews
Volume: 11, Issue: 3
Page: 189-196
Authors: Mutlay Sayan, H. James Wallace III, Ruth Heimann and Brooke T. Mossman

Improvement of malignant pleural mesothelioma immunotherapy by epigenetic modulators

Journal: Current Topics in Medicinal Chemistry
Volume: 16, Issue: 7
Page: 777-787
Authors: Malik Hamaidia, Bernard Staumont, Bernard Duysinx, Renaud Louis and Luc Willems

Mesothelioma - Update on Management

Journal: Current Respiratory Medicine Reviews
Volume: 10, Issue: 4
Page: 206-220
Authors: Patricia Tai, Kurian Joseph, Avi Assouline, Joseph Au and Edward Yu

Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells

Journal: Current Drug Targets
Volume: 15, Issue: 14
Page: 1331-1340
Authors: Leticia G. Leon, Maria Gemelli, Rocco Sciarrillo, Amir Avan, Niccola Funel and Elisa Giovannetti

Statins and Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14, Issue: 5
Page: 706-712
Authors: Natalia G. Vallianou, Alexandra Kostantinou, Marios Kougias and Christos Kazazis

Synthesis and Antiproliferative Activity of Substituted 3[2-(1H-indol-3-yl)- 1,3-thiazol-4-yl]-1H-pyrrolo[3,2-b]pyridines, Marine Alkaloid Nortopsentin Analogues

Journal: Current Medicinal Chemistry
Volume: 21, Issue: 14
Page: 1654-1666
Authors: A. Carbone, M. Pennati, P. Barraja, A. Montalbano, B. Parrino, V. Spano, A. Lopergolo, S. Sbarra, V. Doldi, N. Zaffaroni, G. Cirrincione and P. Diana

The Role of Mesothelin in Tumor Progression and Targeted Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13, Issue: 2
Page: 276-280
Authors: Zhewei Tang, Min Qian and Mitchell Ho

Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13, Issue: 3
Page: 476-482
Authors: Patroklos Katafygiotis, Constantinos Giaginis, Efstratios Patsouris and Stamatios Theocharis

The Role of microRNAs in the Diagnosis and Treatment of Malignant Pleural Mesothelioma - A Short Review

Journal: MicroRNA
Volume: 1, Issue: 1
Page: 40-48
Authors: Kelly W. Sheff, Mir A. Hoda, Balazs Dome, Balazs Hegedus, Walter Klepetko and Glen J. Weiss

Malignant Pleural Mesothelioma in 2011. Is there a Gold Standard Therapy?

Journal: Current Respiratory Medicine Reviews
Volume: 8, Issue: 4
Page: 304-313
Authors: Steven C. Bharadwaj and Alexander S. Farivar

Is α7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?

Journal: Current Drug Targets
Volume: 13, Issue: 5
Page: 688-694
Authors: Alfredo Cesario, Patrizia Russo, Candida Nastrucci and Pierluigi Granone

New Developments in the Management of Pleural Effusions

Journal: Current Respiratory Medicine Reviews
Volume: 2, Issue: 3
Page: 305-311
Authors: Andrew RL Medford and Nick A. Maskell

Antibody-Onconase Conjugates: Cytotoxicity and Intracellular Routing

Journal: Current Pharmaceutical Biotechnology
Volume: 9, Issue: 3
Page: 226-230
Authors: S. M. Rybak

Physiological and Molecular Role of Ranpirnase on Cancer Treatment

Journal: Current Cancer Therapy Reviews
Volume: 6, Issue: 1
Page: 26-33
Authors: Intae Lee, Daehong Kim, Jihean Lee and Kuslima Shogen

Cox Inhibitors as Potential Chemotherapic Drugs for Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 3, Issue: 1
Page: 15-18
Authors: Enrico P. Spugnini, Gennaro Citro and Alfonso Baldi

Hypericin Lights Up the Way for the Potential Treatment of Nasopharyngeal Cancer by Photodynamic Therapy

Journal: Current Clinical Pharmacology
Volume: 1, Issue: 3
Page: 217-222
Authors: Malini Olivo, Hong-Yan Du and Boon-Huat Bay

Antibody-Targeted RNase Fusion Proteins (ImmunoRNases) for Cancer Therapy

Journal: Current Pharmaceutical Biotechnology
Volume: 9, Issue: 3
Page: 231-234
Authors: Jurgen Krauss, Michaela A.E. Arndt, Stefan Dubel and Susanna M. Rybak

Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets

Journal: Current Cancer Drug Targets
Volume: 10, Issue: 1
Page: 19-26
Authors: S. Crispi, I. Cardillo, E. P. Spugnini, G. Citro, S. Menegozzo and A. Baldi

Pleural Fluid Analysis for Evaluating Pleural Effusions

Journal: Current Respiratory Medicine Reviews
Volume: 4, Issue: 3
Page: 217-225
Authors: Jose M. Porcel and Richard W. Light

Development of Novel Therapeutic Strategies for Lung Cancer: Targeting the Cholinergic System

Journal: Current Medicinal Chemistry
Volume: 13, Issue: 29
Page: 3493-3512
Authors: P. Russo, A. Catassi, A. Cesario and D. Servent

Ribonucleases and ImmunoRNases as Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 15, Issue: 23
Page: 2665-2675
Authors: S. M. Rybak, M. A.E. Arndt, T. Schirrmann, S. Dubel and J. Krauss

Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation

Journal: Current Cancer Drug Targets
Volume: 10, Issue: 2
Page: 176-191
Authors: R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio and M. Casto

Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4, Issue: 1
Page: 54-72
Authors: Madeleine Hewish, Ian Chau and David Cunningham

Nicotine, Lung and Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7, Issue: 4
Page: 461-466
Authors: Alessia Grozio, Alessia Catassi, Zita Cavalieri, Laura Paleari, Alfredo Cesario and Patrizia Russo

Molecular Targets in Malignant Pleural Mesothelioma Treatment

Journal: Current Drug Targets
Volume: 10, Issue: 12
Page: 1235-1244
Authors: Giulia Pasello and Adolfo Favaretto

Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?

Journal: Current Medicinal Chemistry
Volume: 17, Issue: 27
Page: 3069-3079
Authors: C. Belli, S. Anand, M. Panella, M. Giovannini, G. Tassi, D. Fennell and L. Mutti

Merlin, a “Magic” Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival

Journal: Current Protein & Peptide Science
Volume: 11, Issue: 6
Page: 471-484
Authors: Ivan Stamenkovic and Qin Yu

Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies

Journal: Current Medicinal Chemistry
Volume: 15, Issue: 7
Page: 631-641
Authors: M. R. Rippo, F. Villanova and A. Procopio

Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?

Journal: Current Cancer Drug Targets
Volume: 9, Issue: 7
Page: 807-823
Authors: H. K. Brown and I. Holen

Dasatinib: An Anti-Tumour Agent via Src Inhibition

Journal: Current Drug Targets
Volume: 12, Issue: 4
Page: 563-578
Authors: Antonio Gnoni, Ilaria Marech, Nicola Silvestris, Angelo Vacca and Vito Lorusso

Mesothelioma - Epidemiology and Management

Journal: Current Respiratory Medicine Reviews
Volume: 7, Issue: 5
Page: 364-376
Authors: Patricia Tai, Edward Yu, Avi Assouline and Kurian Joseph

Molecular Targets and Targeted Therapies for Malignant Mesothelioma

Journal: Current Medicinal Chemistry
Volume: 15, Issue: 9
Page: 855-867
Authors: Camilla Palumbo, Roberto Bei, Antonio Procopio and Andrea Modesti

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11, Issue: 1
Page: 2-11
Authors: Krzysztof Konopa and Jacek Jassem

The Impact of Folate Status on the Efficacy of Colorectal Cancer Treatment

Journal: Current Drug Metabolism
Volume: 12, Issue: 10
Page: 975-984
Authors: Letizia Porcelli, Yehuda G. Assaraf, Amalia Azzariti, Angelo Paradiso, Gerrit Jansen and Godefridus J. Peters

Role of the Non-Neuronal Human Cholinergic System in Lung Cancer and Mesothelioma: Possibility of New Therapeutic Strategies

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4, Issue: 6
Page: 535-542
Authors: Sonya Trombino, Alessandra Bisio, Alessia Catassi, Alfredo Cesario, Carla Falugi and Patrizia Russo

Arginine Deprivation as a Targeted Therapy for Cancer

Journal: Current Pharmaceutical Design
Volume: 14, Issue: 11
Page: 1049-1057
Authors: L. Feun, M. You, C. J. Wu, M. T. Kuo, M. Wangpaichitr, S. Spector and N. Savaraj

Predictive Markers for Haematological Toxicity of Pemetrexed

Journal: Current Drug Targets
Volume: 11, Issue: 1
Page: 48-57
Authors: S. C.H. Kao, V. H. Phan and S. J. Clarke

Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6, Issue: 3
Page: 271-277
Authors: Girolamo Ranieri, Eustachio Ruggieri, Gaetano Falco, Nicola Zizzo, Eliseo Mattioli, Alfredo Francesco Zito, Rosa Patruno and Giampietro Gasparini

Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches

Journal: Current Molecular Pharmacology
Volume: 2, Issue: 2
Page: 190-206
Authors: Marco Tomasetti, Monica Amati, Lory Santarelli, Renata Alleva and Jiri Neuzil

Onconase and Amphinase, the Antitumor Ribonucleases from Rana pipiens Oocytes

Journal: Current Pharmaceutical Biotechnology
Volume: 9, Issue: 3
Page: 215-225
Authors: W. Ardelt, K. Shogen and Z. Darzynkiewicz

The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features

Journal: Current Drug Targets
Volume: 11, Issue: 1
Page: 74-77
Authors: Michael Duruisseaux, Jacques Cadranel, Maurice Perol and Dominique Arpin

Malignant Pleural Effusions: Review of Treatment and Our Experience

Journal: Reviews on Recent Clinical Trials
Volume: 2, Issue: 1
Page: 21-25
Authors: L. Bertolaccini, C. Zamprogna, L. Barberis, M. Navarra, E. Manno, A. D'Urso and F. Massaglia